Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


INTRACRANIAL TUMOUR HAEMORRHAGE side effect

What is INTRACRANIAL TUMOUR HAEMORRHAGE ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   INTRACRANIAL TUMOUR HAEMORRHAGE and Recently Reported Side Effects   INTRACRANIAL TUMOUR HAEMORRHAGE and 15 most Active Side Effect polls   INTRACRANIAL TUMOUR HAEMORRHAGE and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with INTRACRANIAL TUMOUR HAEMORRHAGE

AVONEX  NEXAVAR  TEMODAL  TRASTUZUMAB  WARFARIN  


Temodal Side Effects Report #5548168-8
Physician from JAPAN reported TEMODAL problem on Nov 29, 2007. Female patient, 41 years of age, was diagnosed with malignant glioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, intraocular pressure increased, . TEMODAL dosage: 75 MG/M2;QD;PO. Patient died on 11/19/2007.

Trastuzumab Side Effects Report #5514856-2
TRASTUZUMAB problem was reported by a Physician from UNITED KINGDOM on Oct 29, 2007. Female patient, weighting 154.3 lb, was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, . TRASTUZUMAB dosage: 150 MG, UNK. During the same period patient was treated with PACLITAXEL, BONDRONAT. Patient was hospitalized. Patient recovered.

Avonex Side Effects Report #5500684-0
Physician from UNITED STATES reported AVONEX problem on Oct 15, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, . AVONEX dosage: unknown. Patient died on 07/01/2007.

Temodal Side Effects Report #5385149-1
TEMODAL problem was reported by a Physician from JAPAN on July 05, 2007. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with malignant oligodendroglioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, lymphocyte count decreased, pneumonia, . TEMODAL dosage: 75 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, TAKEPRON OD, AMLODIN, DIOVAN, ASPIRIN, URSO, PREDNISOLONE, AZULFIDINE EN. Patient died on 05/25/2007.


Temodal Side Effects Report #5385149-1
Physician from JAPAN reported TEMODAL problem on July 05, 2007. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with malignant oligodendroglioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: intracranial tumour haemorrhage, lymphocyte count decreased, pneumonia, . TEMODAL dosage: 75 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, TAKEPRON OD, AMLODIN, DIOVAN, ASPIRIN, URSO, PREDNISOLONE, AZULFIDINE EN. Patient died on 05/25/2007.

Trastuzumab Side Effects Report #5531823-3
TRASTUZUMAB problem was reported by a Physician from UNITED KINGDOM on Nov 23, 2007. Female patient, weighting 154.3 lb, was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, intracranial tumour haemorrhage, . TRASTUZUMAB dosage: 150 MG, UNK. During the same period patient was treated with PACLITAXEL, BONDRONAT. Patient was hospitalized. Patient died on 11/06/2007.

Trastuzumab Side Effects Report #5546341-6
Physician from UNITED KINGDOM reported TRASTUZUMAB problem on Nov 26, 2007. Female patient, weighting 154.3 lb, was diagnosed with breast cancer metastatic and was treated with TRASTUZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression, intracranial tumour haemorrhage, polyneuropathy, . TRASTUZUMAB dosage: 150 MG, UNK. During the same period patient was treated with PACLITAXEL, BONDRONAT, TAMOXIFEN CITRATE, ZOLADEX, CISPLATIN, CYCLOPHOSPHAMIDE, EPIRUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 11/06/2007.

Temodal Side Effects Report #5578527-9
TEMODAL problem was reported by a Physician from JAPAN on Dec 21, 2007. Male patient, 66 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, intracranial tumour haemorrhage, . TEMODAL dosage: 150 MG/M2; QD; PO; 150 MG/M2; QD; PO; 150 MG/M2; QD; PO. During the same period patient was treated with NATULAN, CYMERIN, ONCOVIN, DEPAKENE. Patient died on 04/25/2007.

Temodal Side Effects Report #5698381-4
Physician from CANADA reported TEMODAL problem on Mar 28, 2008. Male patient, 17 years of age, weighting 124.1 lb, was diagnosed with astrocytoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: brain oedema, intracranial tumour haemorrhage, neoplasm progression, photophobia, . TEMODAL dosage: 285 MG; QD; PO; 290 MG; QD; PO. During the same period patient was treated with ETOPOSIDE, CODEINE, DIMENHYDRINATE, COTRIMOXAZOLE, ONDANSETRON. Patient was hospitalized. Patient recovered.


Temodal Side Effects Report #5364295-2
TEMODAL problem was reported by a Physician from JAPAN on June 14, 2007. Male patient, 66 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, neoplasm recurrence and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, intracranial tumour haemorrhage, . TEMODAL dosage: unknown. During the same period patient was treated with NATULAN, CYMERIN, ONCOVIN. Patient died on 04/25/2007.

Nexavar Side Effects Report #5574712-0
Health Professional from UNITED STATES reported NEXAVAR problem on Dec 20, 2007. Male patient, 36 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: aphasia, hemiparesis, intracranial tumour haemorrhage, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5492796-5
TEMODAL problem was reported by a Physician from JAPAN on Jan 24, 2007. Female patient, 42 years of age, weighting 145.5 lb, was diagnosed with anaplastic astrocytoma, neoplasm recurrence and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, hepatic function abnormal, intracranial tumour haemorrhage, . TEMODAL dosage: 150 MG/M2;QD;PO. During the same period patient was treated with NIDRAN, PHENYTOIN CAP, BISOLVON, SUCRALFATE, THYRADIN S, ZANTAC. Patient recovered.

Temodal Side Effects Report #5383073-1
Physician from ISRAEL reported TEMODAL problem on June 28, 2007. Female patient, 57 years of age, weighting 147.7 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: asthenia, hypokalaemia, intracranial tumour haemorrhage, leukopenia, pseudomonas infection, thrombocytopenia, transfusion reaction, . TEMODAL dosage: unknown. During the same period patient was treated with SULPHAMETHOXAZOLE, TRIMETHOPRIM. Patient was hospitalized. Patient died on 05/24/2007.

Nexavar Side Effects Report #5393779-6
NEXAVAR problem was reported by a Health Professional from UNITED STATES on July 16, 2007. Male patient, 36 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: aphasia, hemiparesis, intracranial tumour haemorrhage, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.


Temodal Side Effects Report #5383073-1
Physician from ISRAEL reported TEMODAL problem on June 28, 2007. Female patient, 57 years of age, weighting 147.7 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: asthenia, hypokalaemia, intracranial tumour haemorrhage, leukopenia, pseudomonas infection, thrombocytopenia, transfusion reaction, . TEMODAL dosage: unknown. During the same period patient was treated with SULPHAMETHOXAZOLE, TRIMETHOPRIM. Patient was hospitalized. Patient died on 05/24/2007.

Nexavar Side Effects Report #5393779-6
NEXAVAR problem was reported by a Health Professional from UNITED STATES on July 16, 2007. Male patient, 36 years of age, weighting 141.1 lb, was diagnosed with metastatic malignant melanoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: aphasia, hemiparesis, intracranial tumour haemorrhage, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. During the same period patient was treated with CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5766836-X
Physician from JAPAN reported TEMODAL problem on June 03, 2008. Male patient, 74 years of age, weighting 138.9 lb, was diagnosed with glioblastoma, convulsion prophylaxis and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: anaemia, bone marrow failure, intracranial tumour haemorrhage, japan coma scale abnormal, leukopenia, mydriasis, pyrexia, thrombocytopenia, . TEMODAL dosage: 120 MG,QD;PO. During the same period patient was treated with ZONISAMIDE, NORVASC, BLOPRESS, MAGMITT, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient died on 05/10/2008.

Warfarin Side Effects Report #5302828-2
WARFARIN problem was reported by a Health Professional from UNITED STATES on Jan 23, 2007. Male patient, 75 years of age, was diagnosed with coronary arterial stent insertion and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: aphasia, cardiogenic shock, intracranial tumour haemorrhage, . WARFARIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.

Warfarin Side Effects Report #5306168-7
Health Professional from UNITED STATES reported WARFARIN problem on Jan 23, 2007. Male patient, 75 years of age, was diagnosed with coronary arterial stent insertion and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: aphasia, cardiogenic shock, intracranial tumour haemorrhage, . WARFARIN dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.


Temodal Side Effects Report #5281137-4
TEMODAL problem was reported by a Physician from JAPAN on Mar 13, 2007. Male patient, 53 years of age, weighting 125.7 lb, was diagnosed with anaplastic astrocytoma, recurrent cancer and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, dehydration, intracranial tumour haemorrhage, neoplasm progression, pneumonia, . TEMODAL dosage: 150 MG/M2; QD; PO. During the same period patient was treated with SELBEX, LEXIN, SELENICA, PROTECADIN, MAGNESIUM OXIDE, RINDERON. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about INTRACRANIAL TUMOUR HAEMORRHAGE side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about INTRACRANIAL TUMOUR HAEMORRHAGE